This presidential action document lists numerous individuals whom the President has nominated to key positions within the Executive Branch and the Federal Judiciary, including appointments to the U.S. Postal Service Board of Governors, ambassadorships, departmental assistant secretary roles, the directorship of the NSF, U.S. Attorney and Marshal posts, and several vacancies on the U.S. District Courts and the U.S. Court of International Trade, all awaiting Senate confirmation.

This document lists a specific nomination sent by the President to the Senate for confirmation: Michael McDonald of the District of Columbia, to serve as Chairperson of the National Endowment for the Humanities for a four-year term, replacing Shelly C. Lowe.

This Presidential Proclamation, issued under Section 232 of the Trade Expansion Act of 1962, addresses the finding that imports of semiconductors, semiconductor manufacturing equipment, and their derivatives threaten U.S. national security due to insufficient domestic production capacity.

The President adopts a two-phase plan, beginning with directing negotiations with foreign jurisdictions while immediately imposing a 25 percent ad valorem tariff on a narrow category of advanced computing chips unless the importation supports U.S. technology supply chain buildout or domestic manufacturing.

The proclamation aims to reduce reliance on foreign supply chains essential for defense and critical infrastructure development.

This Presidential Proclamation announces a finding, based on a report from the Secretary of Commerce under Section 232 of the Trade Expansion Act of 1962, that imports of Processed Critical Minerals and their Derivative Products (PCMDPs) threaten U.S. national security due to excessive foreign reliance, supply chain insecurity, and domestic production decline. The President concurs with the finding and directs the Secretary of Commerce and the United States Trade Representative to jointly negotiate agreements with trading partners to adjust these imports, specifying that if satisfactory agreements are not reached within 180 days, alternative remedies like tariffs or minimum import prices may be considered.

This document provides a compilation of numerous individuals nominated by the President to various high-level federal positions, including roles within executive departments, independent agencies, ambassadorships, and U.S. Attorney offices.

The listings specify the nominee's name, their proposed role, the agency or location, and often denote whether the appointment is to fill an expired term, a vacancy, or a newly created position, detailing the necessary Senate confirmation required for these appointments to take effect.

This document, categorized under Presidential Actions, lists several nominations sent to the Senate for confirmation, primarily consisting of appointments for United States Attorneys for various districts and nominations for United States District Judges across several states.

This Presidential Action establishes comprehensive policy priorities to assert United States superiority in space, focusing on four key areas: leading exploration through a return to the Moon by 2028 and establishing a permanent lunar outpost by 2030; securing national and economic security interests against space threats; fostering a robust commercial space economy projected to attract $50 billion in new investment by 2028; and developing advanced capabilities, including deploying lunar nuclear power by 2030.

The order outlines specific implementation timelines, assigns coordination roles to various White House offices and agency heads, mandates significant reforms to NASA and Commerce acquisition processes, and supersedes prior related directives, including the revocation of Executive Order 14056.

This Presidential Action establishes that Americans deserve better access to medical research on marijuana and cannabidiol (CBD) to address conditions like chronic pain, noting that decades of restrictive federal policy have limited necessary investigations.

The order directs the Attorney General to immediately complete the process of rescheduling marijuana to Schedule III of the Controlled Substances Act (CSA), reflecting the Department of Health and Human Services' recommendation that it has accepted medical use.

Furthermore, the action mandates collaboration with Congress to clarify the regulation of hemp-derived cannabinoid products, including setting THC limits, while tasking HHS and other agencies to develop research models using real-world evidence to improve patient guidance and product safeguards.